Option chain shows key data for Radient Technologies's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Radient Technologies.

Radient Technologies (OTC:RDDTF) Stock, Option Chain

Radient Technologies

Radient Technologies Inc is a Canadian company engaged in manufacturing cannabis derivatives, formulations, and products. It has developed its extraction process, Microwave Assisted Processing (MAP), which is used for producing a consistent product at industrial-scale quantities. It provides its customers and partners with white-label extracts, formulations, and finished products that contain a broad spectrum of cannabinoid and terpene profiles. While it operates in Canada and is building an additional facility in Germany. It operates in a single segment namely the production and sale of cannabis-related retail products.

Cannabis

News

Markets

RDDTF

TSXV:RTI

Radient Technologies Inc. (OTCPK:RDDTF) (TSXV: RTI) , a commercial manufacturer cannabis extracts and packaged products, has closed the second and final tranche of its non-brokered private placement of up to 30 units. 

Radient Closes Second And Final Tranche Of Financing

Earnings

Radient Technologies Inc. (OTCPK:RDDTF) (TSXV: RTI) released its financial results for the quarter ended December 31, 2022, revealing revenue of $1 million, a decrease of 37% compared to $1.6 million in the same period in the prior year.

Q3 FY 2023 Financial Highlights

Radient Technologies Q3 FY23 Revenue Declines 37% YoY, Here Are The Details

Radient Technologies Inc. (OTCPK:RDDTF) (TSXV: RTI), revenue for the quarter ended June 30, 2022, was CA$569,414, ($415,000) a 24% decrease compared to CA$749,222 in the same period in the prior year.

Cannabis Company Betting On Hydrocarbon Concentrates Looking For A Way Out Of Debt

RADIENT TECH INC ORD by Radient Technologies Inc

Radient Technologies Inc

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterates Intensity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTS#NASDAQ">INTS</a>) with a Buy and maintains $5 price target.

Price Target

Reiteration

Analyst Ratings

INTS

HC Wainwright & Co. Reiterates Buy on Intensity Therapeutics, Maintains $5 Price Target

President-elect Donald Trump&#8216;s pick for attorney general in his second administration, former U.S. Rep. Matt Gaetz, withdrew his name from consideration on Thursday. The Florida Republican who was poised to be nominated as the nation&#8217;s top cop has previously been in the legal crosshairs himself in multiple <a href="https://www.benzinga.com/news/legal/24/11/42078192/trumps-attorney-general-pick-matt-gaetz-resigned-from-congress-ethics-committee-to-decide-if-report-will-be-released">sex trafficking investigations</a>.
Gaetz Bows Out: Gaetz announced the decision in a Thursday <a href="https://x.com/mattgaetz/status/1859649045553402285">post</a> on X.
&#8220;I had excellent meetings with Senators yesterday. I appreciate their thoughtful feedback &#8211; and the incredible support of so many. While the momentum was strong, it is clear that my confirmation was unfairly becoming a distraction to the critical work of the Trump/Vance Transition,&#8221; Gaetz posted.
&#8220;There is no time to waste on a needlessly protracted Washington scuffle, thus I&#8217;ll be withdrawing my name from consideration to serve as Attorney General. Trump&#8217;s DOJ must be in place and ready on Day 1,&#8221; he continued.
Earlier Developments: Gaetz, who resigned from Congress Nov. 13 following Trump&#8217;s announcement, had previously been under federal and congressional investigation.
The New York Times <a href="https://www.nytimes.com/2024/11/20/us/politics/matt-gaetz-venmo-payments-sex.html">obtained</a> a redacted document from the federal investigation, which was later dropped, on Wednesday.
The document includes a map created by investigators alleging that Gaetz sent thousands of dollars to women and associate Joel Greenberg, who previously pleaded guilty to sex trafficking charges, on Venmo. According to testimony, the individuals who received the money were involved in &#8220;sex parties&#8221; from 2017 to 2020. Gaetz also allegedly paid $450 to a 17-year-old.
ABC News <a href="https://abcnews.go.com/US/gaetz-10k-venmo-payments-2-women-testified-house/story?id=116019367">obtained</a> a document from the House Ethics Committee with similar findings on Wednesday.
The separate investigation found that Gaetz sent over $10,000 on Venmo to women who testified in the House probe. Transactions included Gaetz&#8217;s notes for the women, including &#8220;being my friend,&#8221; &#8220;extra 4 u&#8221; and &#8220;being awesome.&#8221; These transactions totaled over $1,000, the report said. 
The House investigation ended when Gaetz resigned.
Why it Matters: Gaetz faced a tough path to confirmation in a Republican-controlled Senate. The Republican party will hold a 53-47 majority come January. Still, only four GOP defections — perhaps Susan Collins (R-ME), Lisa Murkowski (R-AK), Thom Tillis (R-NC) and Bill Cassidy (R-LA) — would have sunk Gaetz&#8217;s nomination.
It is now unclear who Trump will select to fill the AG role. Traders on prediction market <a href="https://polymarket.com/event/who-will-be-trumps-attorney-general">Polymarket</a> quickly reacted to Gaetz&#8217;s announcement. Trump&#8217;s pick for deputy AG, Todd Blanche, is the betting favorite.
Blanche represented Trump during a trial in New York state, during which the former president was found guilty of felony falsification of business records.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42112078/international-criminal-court-issues-arrest-warrants-for-netanyahu-gallant">International Criminal Court Issues Arrest Warrants For Israeli Prime Minister Netanyahu, Gallant For War Crimes</a></li>
</ul>

Government

Politics

Legal

Matt Gaetz Withdraws Name From AG Nomination, Calls Sex Trafficking Scandal 'Distraction'

<a href="https://www.wsj.com/business/deals/building-materials-provider-quikrete-in-advanced-talks-to-buy-rival-b926c088?mod=latest_headlines">https://www.wsj.com/business/deals/building-materials-provider-quikrete-in-advanced-talks-to-buy-rival-b926c088?mod=latest_headlines</a>
&nbsp;
Building-materials provider Quikrete is in advanced talks to acquire rival <a href="https://www.wsj.com/market-data/quotes/SUM">Summit Materials</a>, according to people familiar with the matter.&nbsp;
A deal between closely held Quikrete and Summit could be announced early next week, said the people, assuming the talks don't fall apart.&nbsp;

'Building-Materials Provider Quikrete In Advanced Talks To Buy Rival; Deal For Summit Materials Could Come Together Early Next Week' - WSJ

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates NovoCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) with a Buy and maintains $30 price target.

NVCR

HC Wainwright & Co. Reiterates Buy on NovoCure, Maintains $30 Price Target

WIIM

EVLV

Evolv Technology shares are trading higher after the company announced the results of its internal investigation and announced its CFO has resigned.

Needham analyst Ami Fadia reiterates Jazz Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAZZ#NASDAQ">JAZZ</a>) with a Buy and maintains $207 price target.

JAZZ

Needham Reiterates Buy on Jazz Pharmaceuticals, Maintains $207 Price Target

Truist Securities analyst Jasper Bibb maintains Universal Technical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTI#NYSE">UTI</a>) with a Buy and raises the price target from $22 to $26.

Truist Securities Maintains Buy on Universal Technical, Raises Price Target to $26

Goldman Sachs analyst Catherine O&#8217;Brien expressed views on Delta Air Lines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) Investor Day in New York yesterday.
Delta&#8217;s three-to-five-year financial framework targets mid-teens operating margins, 10% average annual EPS growth, and<a target="_blank" href="https://www.benzinga.com/24/11/42087211/delta-charts-its-path-to-high-margins-and-shareholder-gains-at-2024-investor-day" rel="noreferrer noopener"> $3 billion-$5 billion in annual free cash flow</a>.
Delta&nbsp;reaffirmed its expected&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41270201/deltas-turbulent-q3-mixed-results-and-tech-troubles-cloud-holiday-outlook" rel="noreferrer noopener">fourth-quarter financial guidance</a>.
The company also provided preliminary commentary on 2025 for capacity growth of three to four percent year-over-year, revenue growth of mid-single digits and non-fuel unit cost growth of low-single digits year-over-year.&nbsp;
The analyst maintained a <a target="_blank" href="https://www.benzinga.com/quote/DAL/analyst-rating" rel="noreferrer noopener">Buy rating</a> on Delta Air Lines. O&#8217;Brien writes that Delta plans to strengthen its segmentation strategy by testing new products in Main Cabin starting in 2025.
The analyst also notes that the airline&#8217;s premium products drive the highest margins, with stable demand evidenced by an 85% repurchase rate.
O&#8217;Brien writes that Delta&#8217;s solid balance sheet includes new targets of 1.0x gross leverage and $40 billion in unencumbered assets, which will provide financial durability through market cycles.
The analyst estimates EPS of $6.05 in FY24, $8.25 in FY25 and $9.50 in FY26.
Investors can gain exposure to the stock via U.S. Global Jets ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JETS#NYSE">JETS</a>) and Defiance Hotel, Airline, and Cruise ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRUZ#NYSE">CRUZ</a>).
Price Action: DAL shares are up 1.21% at $64.41 at the last check Thursday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/11/42106369/delta-chief-says-trump-could-be-a-breath-of-fresh-air-for-aviation-industry" target="_blank" rel="noreferrer noopener">Delta Chief Says Trump Could Be A &#8216;Breath Of Fresh Air&#8217; For Aviation Industry</a></li>
</ul>

Analyst Color

Equities

Large Cap

Trading Ideas

CRUZ

JETS

Goldman Sachs Sees Delta's Long-Term Growth On Track: EPS To Hit $9.50 By FY26

Truist Securities analyst Ki Bin Kim maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Buy and maintains $210 price target.

SNOW

Truist Securities Maintains Buy on Snowflake, Maintains $210 Price Target

Palo Alto Networks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) shares are trading higher Thursday. The cybersecurity company reported fiscal first-quarter earnings results after the market close on Wednesday. Here&#8217;s <a href="https://www.benzinga.com/news/earnings/24/11/42099690/palo-alto-networks-q1-earnings-revenue-beat-eps-beat-2-for-1-stock-split-multiyear-platformization-trend-for-security-ai">what you need to know.</a>
What To Know: Palo Alto Networks reported revenue of $2.14 billion, surpassing the consensus estimate of $2.12 billion. Quarterly earnings came in at $1.56 per share, beating analyst estimates of $1.48 per share, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
Revenue was up 14% year-over-year, with remaining performance obligations growing by 20% to $12.6 billion. Additionally, the company&#8217;s next-generation security annual recurring revenue rose by 40% year-over-year to $4.5 billion.
&#8220;Our Q1 results reinforced our conviction in our differentiated platformization strategy,&#8221; said Nikesh Arora, chairman and CEO of Palo Alto Networks.
The company also announced a two-for-one stock split, which is scheduled to take effect on Dec. 16, with a record date of Dec. 12. Shareholders will receive one additional share for each share they held as of the market close on Dec. 13.
Looking ahead, Palo Alto expects second-quarter fiscal 2025 revenue in the range of $2.22 billion to $2.25 billion and adjusted earnings per share between $1.54 and $1.56. For the full fiscal year, the company anticipates revenue between $9.12 billion and $9.17 billion and earnings between $6.26 and $6.39 per share.
Following the print, analysts maintained <a href="https://www.benzinga.com/news/earnings/earnings-beats/24/11/42116266/palo-alto-networks-posts-q3-beat-analysts-are-most-impressed-by-platform-acceleration">generally positive ratings</a>, with price target adjustments reflecting the strong performance. Price targets from analysts on Thursday ranged from $370 to $450 per share. Needham and Wells Fargo both raised their targets to $450, while Oppenheimer and RBC Capital maintained price targets of $450. 
PANW Price Action: Palo Alto Networks shares were up 2.13% at $401.41 at the time of publication, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/asset-sales/24/11/42117962/starbucks-eyes-stake-sale-in-china-amid-fierce-competition-and-falling-sales">Starbucks Eyes Stake Sale in China Amid Fierce Competition and Falling Sales</a></li>
</ul>
Image Via Shutterstock.

Movers

PANW

What's Going On With Palo Alto Networks Stock Thursday?

Truist Securities analyst Anthony Hau maintains Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) with a Buy and maintains $425 price target.

Truist Securities Maintains Buy on Palo Alto Networks, Maintains $425 Price Target

D. Boral Capital analyst Jesse Sobelson maintains American Res (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREC#NASDAQ">AREC</a>) with a Buy and maintains $4 price target.

AREC

D. Boral Capital Maintains Buy on American Res, Maintains $4 Price Target

Live On CNBC, Josh Brown Announces Cut Pfizer Position By Half

Telsey Advisory Group analyst Dana Telsey maintains TJX Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) with a Outperform and maintains $134 price target.

Telsey Advisory Group Maintains Outperform on TJX Companies, Maintains $134 Price Target

Deep-pocketed investors have adopted a bearish approach towards Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in INTU usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 16 extraordinary options activities for Intuit. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 43% bearish. Among these notable options, 4 are puts, totaling $398,526, and 12 are calls, amounting to $1,353,523.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $600.0 and $760.0 for Intuit, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Intuit's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Intuit's significant trades, within a strike price range of $600.0 to $760.0, over the past month.
<h3>Intuit Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732211315_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>INTU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$24.9</td>
<td>$23.0</td>
<td>$23.0</td>
<td>$680.00</td>
<td>$782.0K</td>
<td align="right">205</td>
<td align="right">341</td>
</tr>
<tr>
<td>INTU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$13.4</td>
<td>$10.9</td>
<td>$12.9</td>
<td>$620.00</td>
<td>$258.0K</td>
<td align="right">344</td>
<td align="right">200</td>
</tr>
<tr>
<td>INTU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$14.6</td>
<td>$14.6</td>
<td>$14.6</td>
<td>$720.00</td>
<td>$91.9K</td>
<td align="right">530</td>
<td align="right">64</td>
</tr>
<tr>
<td>INTU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$8.3</td>
<td>$8.0</td>
<td>$8.3</td>
<td>$600.00</td>
<td>$83.0K</td>
<td align="right">307</td>
<td align="right">104</td>
</tr>
<tr>
<td>INTU</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/29/24</td>
<td>$50.6</td>
<td>$44.7</td>
<td>$47.65</td>
<td>$630.00</td>
<td>$81.0K</td>
<td align="right">24</td>
<td align="right">17</td>
</tr>
</tbody>
</table>

<h3>About Intuit</h3>
Intuit is a provider of small-business accounting software (QuickBooks), personal tax solutions (TurboTax), and professional tax offerings (Lacerte). Founded in the mid-1980s, Intuit controls the majority of US market share for small-business accounting and do-it-yourself tax-filing software.
<h3>Where Is Intuit Standing Right Now?</h3>
<ul>
<li>With a volume of 848,632, the price of INTU is up 3.98% at $676.48. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 0 days.</li>
</ul>
<h3>What Analysts Are Saying About Intuit</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $750.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Intuit, which currently sits at a price target of $800. 
&#x2A; In a cautious move, an analyst from Scotiabank downgraded its rating to Sector Perform, setting a price target of $700. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Intuit, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

INTU

Intuit Options Trading: A Deep Dive into Market Sentiment

Financial giants have made a conspicuous bearish move on Red Cat Hldgs. Our analysis of options history for Red Cat Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) revealed 10 unusual trades.
Delving into the details, we found 40% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $248,470, and 7 were calls, valued at $246,565.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $5.0 to $12.0 for Red Cat Hldgs over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Red Cat Hldgs stands at 1970.57, with a total volume reaching 6,692.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Red Cat Hldgs, situated within the strike price corridor from $5.0 to $12.0, throughout the last 30 days.
<h3>Red Cat Hldgs Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732211309_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RCAT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$5.1</td>
<td>$4.8</td>
<td>$5.06</td>
<td>$12.00</td>
<td>$101.9K</td>
<td>0</td>
<td>720</td>
</tr>
<tr>
<td>RCAT</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$4.9</td>
<td>$4.5</td>
<td>$4.7</td>
<td>$12.00</td>
<td>$93.5K</td>
<td>0</td>
<td>920</td>
</tr>
<tr>
<td>RCAT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$5.4</td>
<td>$5.3</td>
<td>$5.3</td>
<td>$12.00</td>
<td>$53.0K</td>
<td>0</td>
<td>110</td>
</tr>
<tr>
<td>RCAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$1.4</td>
<td>$1.25</td>
<td>$1.27</td>
<td>$8.00</td>
<td>$50.9K</td>
<td>2.6K</td>
<td>2.0K</td>
</tr>
<tr>
<td>RCAT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$3.1</td>
<td>$2.95</td>
<td>$2.95</td>
<td>$5.00</td>
<td>$44.2K</td>
<td>2.8K</td>
<td>338</td>
</tr>
</tbody>
</table>

<h3>About Red Cat Hldgs</h3>
Red Cat Holdings Inc is a military technology company that integrates robotic hardware and software to provide critical situational awareness and actionable intelligence to on-the-ground warfighters and battlefield commanders. Its mission is to enhance the effectiveness and safety of military operations domestically and globally. Red Cat's suite of solutions includes Teal Drones, developer of the Golden Eagle, a small unmanned system with the highest resolution imaging for night-time operations, and Skypersonic, a provider of unmanned aircraft for interior spaces and other dangerous environments.
Having examined the options trading patterns of Red Cat Hldgs, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Red Cat Hldgs</h3>
<ul>
<li>With a volume of 10,495,244, the price of RCAT is up 21.98% at $7.77. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 22 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Red Cat Hldgs, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

RCAT

Red Cat Hldgs's Options Frenzy: What You Need to Know

Deep-pocketed investors have adopted a bearish approach towards Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GAP usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Gap. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 12% leaning bullish and 62% bearish. Among these notable options, 4 are puts, totaling $145,250, and 4 are calls, amounting to $135,267.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $19.5 to $24.0 for Gap over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Gap options trades today is 835.88 with a total volume of 2,437.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Gap's big money trades within a strike price range of $19.5 to $24.0 over the last 30 days.
<h3>Gap Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732211304_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GAP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$0.89</td>
<td>$0.82</td>
<td>$0.89</td>
<td>$19.50</td>
<td>$44.5K</td>
<td>603</td>
<td align="right">503</td>
</tr>
<tr>
<td>GAP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$0.89</td>
<td>$0.62</td>
<td>$0.89</td>
<td>$23.00</td>
<td>$44.5K</td>
<td>328</td>
<td align="right">0</td>
</tr>
<tr>
<td>GAP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$5.45</td>
<td>$5.3</td>
<td>$5.4</td>
<td>$24.00</td>
<td>$39.4K</td>
<td>24</td>
<td align="right">75</td>
</tr>
<tr>
<td>GAP</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/22/24</td>
<td>$1.04</td>
<td>$0.77</td>
<td>$0.9</td>
<td>$22.50</td>
<td>$35.1K</td>
<td>1.0K</td>
<td align="right">407</td>
</tr>
<tr>
<td>GAP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$4.15</td>
<td>$4.05</td>
<td>$4.15</td>
<td>$22.00</td>
<td>$31.9K</td>
<td>105</td>
<td align="right">77</td>
</tr>
</tbody>
</table>

<h3>About Gap</h3>
Gap retails apparel, accessories, and personal-care products under the Gap, Old Navy, Banana Republic, and Athleta brands. Old Navy generates more than half of Gap's sales. The firm also operates e-commerce sites, outlet stores, and specialty stores under various Gap names. Gap operates approximately 2,500 stores in North America, Europe, and Asia and franchises about 1,000 more in Asia, Europe, Latin America, and other regions. Gap was founded in 1969 and is based in San Francisco.
After a thorough review of the options trading surrounding Gap, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Gap</h3>
<ul>
<li>Currently trading with a volume of 4,813,202, the GAP's price is up by 2.96%, now at $21.23. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 0 days.</li>
</ul>
<h3>Expert Opinions on Gap</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $27.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Telsey Advisory Group keeps a Market Perform rating on Gap with a target price of $26. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on Gap, maintaining a target price of $28. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Gap with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Spotlight on Gap: Analyzing the Surge in Options Activity

Eli Lilly and Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) has seen better days. The stock is up 26.04% for the last year but has struggled recently, falling 17.57% over <a href="https://www.benzinga.com/quote/LLY/news">the last month</a>.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="628" height="490" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21061153/Screenshot-2024-11-21-at-4.40.52-PM.png" alt="" class="wp-image-658564" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21061153/Screenshot-2024-11-21-at-4.40.52-PM.png 628w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21061153/Screenshot-2024-11-21-at-4.40.52-PM-300x234.png 300w" sizes="(max-width: 628px) 100vw, 628px" /></a></figure>
<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112124&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
Lilly stock is well below its summer highs and is trading at $746.94 at the time of writing. The once red-hot obesity drugmaker is in the crosshairs of bearish technicals and political uncertainty.
Could the selloff be an overreaction?
Read Also: <a href="https://www.benzinga.com/24/11/42097813/eli-lilly-opts-to-develop-candidate-for-nervous-system-disease">Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate</a>
<h2 class="wp-block-heading">Bearish Signals Galore For LLY Stock</h2>
Lilly stock is trading beneath its eight-, 20-, and 50-day exponential moving averages, firmly positioning it in a bearish trend. The Relative Strength Index (RSI) of 33.02 indicates the stock is teetering on oversold territory, while the MACD at negative 37.55 confirms strong downward momentum.
Even the 200-day simple moving average of $835.76 is now a distant memory, amplifying concerns.
<h2 class="wp-block-heading">Kennedy Sends Drugmakers Tumbling</h2>
The broader selloff in anti-obesity drugmakers like Eli Lilly, Novo Nordisk AS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) and Amgen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) has been linked to fears over the possible appointment by President-elect Donald Trump of Robert F. Kennedy Jr. as head of the Department of Health and Human Services.
Investors worry his critical stance on GLP-1 weight-loss treatments could lead to reduced insurance coverage or pricing pressures. While the agency has limited power to enact sweeping changes without Congress, the uncertainty has spooked the market.
<h2 class="wp-block-heading">Still Room To Run?</h2>
For contrarian investors, the fundamentals paint a different picture. Eli Lilly's Zepbound and Mounjaro sales are projected to hit $18 billion by 2026, doubling from 2024 estimates.
Total revenue is expected to climb to $69 billion by 2026, with earnings soaring to $30 per share — more than double the current $13.26.
And at 33.2 times forward earnings (per <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112124&amp;t=be2bearmibe3na1">Benzinga Pro</a> data), the stock's valuation looks far more attractive than its July peak of 57.2 times.
<h2 class="wp-block-heading">What's Next?</h2>
Jim Cramer's take sums up the contrarian sentiment: "This stock is as hated now as it was loved not that long ago. I think it's a buy&#8230; enough on the selling."
For long-term investors, Eli Lilly's dominance in the burgeoning obesity drug market remains a compelling growth story. 
Whether the selloff is a red flag or a golden opportunity may depend on how much faith investors have in the fundamentals.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/health-care/24/11/42097386/cvs-healthcignaunitedhealths-pharmacy-benefit-managers-accuse-ftc-of-overreach-in-effort-to-reshape-drug-rebate-system">Big Pharma&#8217;s Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System</a></li>
</ul>
Photo courtesy of Eli Lilly.

Biotech

Long Ideas

Health Care

Technicals

General

AMGN

Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs

Live On CNBC, Josh Brown Announces Bought Block, Inc.

Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>) with a Outperform and maintains $108 price target.

USPH

Barrington Research Maintains Outperform on US Physical Therapy, Maintains $108 Price Target

Radient Technologies Inc (RDDTF) stock is unmoved 0.00% over the last 12 months. InvestorsObserver's proprietary ranking system, gives RDDTF stock a score of  0 out of a possible 100. That rank is chiefly influenced by a short-term technical score of 0. RDDTF's rank also includes a long-term technical score of 0.  RDDTF ha

Should You Sell Radient Technologies Inc (RDDTF) Stock Tuesday?

Radient Technologies Inc (RDDTF) is around the bottom of the Healthcare sector according to InvestorsObserver.RDDTF received an overall rating of 0, which means that it scores higher than 0% of stocks. Additionally, Radient Technologies Inc scored a 0 in the Healthcare sector, ranking it higher than 0% of stocks in that se

Is Radient Technologies Inc (RDDTF) a Laggard in the Healthcare Sector?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
There have been a number of high-profile stock mixups in the past that have led certain <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a> to skyrocket in a short amount of time before dying back down. One such stock generating an incredible amount of interest today is Radient Technologies (OTCMKTS:<a href="https://investorplace.com/stock-quotes/rddtf-stock-quote/">RDDTF</a>). Indeed, shares of RDDTF stock are up more than 4,900% on the same day as the Reddit (NYSE:<a href="https://investorplace.com/stock-quotes/rddt-stock-quote/">RDDT</a>) initial public offering (IPO).



That&rsquo;s right, the IPO that has brought RDDT stock and Reddit to market has led to a fat-finger trade that has sent shares of this penny stock to the stratosphere. Valued at around $2 million for most of the past year, Radient Technologies&rsquo; market capitalization last sat <a href="https://finance.yahoo.com/quote/RDDTF?.tsrc=fin-srch">just shy of $1 billion</a> today, suggesting someone made a mistake.



Let&rsquo;s dive into what to make of this mixup for investors following the Reddit IPO today.



<h2>RDDTF Stock Surges on Reddit IPO Day</h2>



Reddit&rsquo;s IPO has certainly been met with some incredible enthusiasm, with RDDT stock surging more than 40% on its first day as a public company. This move represents the kind of outsized attention an IPO of this size was bound to see, although the fact RDDT is trading this much higher may be a surprise to some.



So, this trade for Radient Technologies stock appears to simply be a mixup between some trader placing a trade for RDDT stock at multiples higher than it was worth (it was only a trade for 294 shares, and since no other shares have traded hands since this writing, it appears the stock isn&rsquo;t moving at this price). 



This isn&rsquo;t the first time we&rsquo;ve seen this. Previous examples of fat-fingered trades include investors <a href="https://investorplace.com/2021/01/signal-stock-confusion-did-elon-musk-tweet-have-investors-piling-into-sigl-stock/">piling</a> into Signal Advance (OTCMKTS:<a href="https://investorplace.com/stock-quotes/sigl-stock-quote/">SIGL</a>) following a tweet from Tesla (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsla-stock-quote/">TSLA</a>) CEO Elon Musk to &ldquo;use Signal&rdquo; and investors <a href="https://investorplace.com/2021/01/hey-amcx-stock-investors-did-you-mean-to-buy-amc-reddit-wsb/">bidding up</a> AMC Networks&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/amcx-stock-quote/">AMCX</a>) stock following the 2021 meme stock rally seen in AMC Entertainment&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/amc-stock-quote/">AMC</a>). 



It&rsquo;s also not going to be the last such example. For now, I think this move in Radient Technologies is one most investors can brush off, with plenty of other stocks seeing large moves that may be sustainable. I&rsquo;d expect to see RDDTF stock move lower toward where it has been trading for most of the year in short order.



On the date of publication, Chris MacDonald did not hold (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.
<div>Chris MacDonald&rsquo;s love for investing led him to pursue an MBA in Finance and take on a number of management roles in corporate finance and venture capital over the past 15 years. His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/03/radient-technologies-rddtf-stock-skyrockets-4900-in-apparent-reddit-mixup/">Radient Technologies (RDDTF) Stock Skyrockets 4,900% in Apparent Reddit Mixup</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Radient Technologies (RDDTF) Stock Skyrockets 4,900% in Apparent Reddit Mixup

The past, present and future of the Canadian cannabis sector based on the performance of the, MCCCI, which is a proprietary index of 14 stocks.

Comments

Radient Technologies

Radient Technologies (RDDTF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga